Published in Br J Pharmacol on July 01, 1993
P2 receptor subtypes in the cardiovascular system. Biochem J (1998) 1.60
Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmacol (1994) 1.39
Contribution of ATP and nitric oxide to NANC inhibitory transmission in rat pyloric sphincter. Br J Pharmacol (1994) 0.90
The P(2)-purinoceptor antagonist suramin is a competitive antagonist at vasoactive intestinal peptide receptors in the rat gastric fundus. Br J Pharmacol (2000) 0.88
ATP and nitric oxide: inhibitory NANC neurotransmitters in the longitudinal muscle-myenteric plexus preparation of the rat ileum. Br J Pharmacol (1996) 0.86
Endothelial nitric oxide modulates perivascular sensory neurotransmission in the rat isolated mesenteric arterial bed. Br J Pharmacol (2002) 0.84
The innervation of rainbow trout (Oncorhynchus mykiss) liver: protein gene product 9.5 and neuronal nitric oxide synthase immunoreactivities. J Anat (1998) 0.81
Localisation of immunoreactive factor VIII, nitric oxide synthase, substance P, endothelin-1 and 5-hydroxytryptamine in human postmortem middle cerebral artery. J Anat (1996) 0.78
Biphasic neurogenic vasodilatation in the bovine intraocular long posterior ciliary artery: involvement of nitric oxide and an additional unidentified neurotransmitter. Br J Pharmacol (2005) 0.78
The transhepatic action of ATP on the hepatic arterial and portal venous vascular beds of the rabbit: the role of nitric oxide. Br J Pharmacol (1994) 0.78
Purinergic receptors in the splanchnic circulation. Purinergic Signal (2008) 0.75
Biphasic effects of NMDA on the motility of the rat portal vein. Br J Pharmacol (2000) 0.75
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44
Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol (1990) 8.85
Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci U S A (1991) 3.67
Do some nerve cells release more than one transmitter? Neuroscience (1976) 2.54
Nitrergic transmission: nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission. Clin Exp Pharmacol Physiol (1992) 2.16
Evidence for two types of P2-purinoceptor in longitudinal muscle of the rabbit portal vein. Eur J Pharmacol (1985) 1.43
Nitric oxide synthase in cardiac nerve fibers and neurons of rat and guinea pig heart. Circ Res (1992) 1.30
Flow-induced release of adenosine 5'-triphosphate from endothelial cells of the rat mesenteric arterial bed. Experientia (1992) 0.94
Comparative pharmacological and histochemical evidence for purinergic inhibitory innervation of the portal vein of the rabbit, but not guinea-pig. Br J Pharmacol (1979) 0.93
An analysis of the responses of the isolated portal vein of the rabbit to electrical stimulation and to drugs. Br J Pharmacol Chemother (1967) 0.83
Receptors for purines and pyrimidines. Pharmacol Rev (1998) 13.92
Purinergic nerves. Pharmacol Rev (1972) 12.05
Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol (1985) 9.20
Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol (1970) 8.20
The inhibitory innervation of the taenia of the guinea-pig caecum. J Physiol (1966) 5.53
Nomenclature and classification of purinoceptors. Pharmacol Rev (1994) 5.32
A P2X purinoceptor expressed by a subset of sensory neurons. Nature (1995) 4.86
Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature (2000) 4.53
Transmission from intramural inhibitory nerves to the smooth muscle of the guinea-pig taenia coli. J Physiol (1966) 4.22
Apamin blocks certain neurotransmitter-induced increases in potassium permeability. Nature (1979) 3.93
Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther (1994) 3.93
The use of the slowly degradable analog, alpha, beta-methylene ATP, to produce desensitisation of the P2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder. Eur J Pharmacol (1982) 3.52
Alcoholism susceptibility loci: confirmation studies in a replicate sample and further mapping. Alcohol Clin Exp Res (2000) 3.42
Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett (1993) 3.38
Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli. Br J Pharmacol (1990) 3.34
ATP as a co-transmitter in rat tail artery. Eur J Pharmacol (1984) 3.28
International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev (2001) 3.26
Inhibition of excitatory junction potentials in guinea-pig vas deferens by alpha, beta-methylene-ATP: further evidence for ATP and noradrenaline as cotransmitters. Eur J Pharmacol (1984) 3.24
P2-purinoceptors of two subtypes in the rabbit mesenteric artery: reactive blue 2 selectively inhibits responses mediated via the P2y-but not the P2x-purinoceptor. Br J Pharmacol (1987) 3.15
Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide. Br J Pharmacol (1972) 2.93
Review lecture. Neurotransmitters and trophic factors in the autonomic nervous system. J Physiol (1981) 2.85
Purinergic innervation of the guinea-pig urinary bladder. Br J Pharmacol (1978) 2.61
G protein-coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol Sci (1994) 2.57
Transmission from perivascular inhibitory nerves to the smooth muscle of the guinea-pig taenia coli. J Physiol (1966) 2.48
P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J Neurosci (2001) 2.41
Evidence that ATP acts as a co-transmitter with noradrenaline in sympathetic nerves supplying the guinea-pig vas deferens. Eur J Pharmacol (1983) 2.40
Purinergic signalling: ATP release. Neurochem Res (2001) 2.33
Evidence that prostaglandin is responsible for the 'rebound contraction' following stimulation of non-adrenergic, non-cholinergic ('purinergic') inhibitory nerves. Eur J Pharmacol (1975) 2.09
Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci (1997) 2.09
Evidence for purinergic innervation of the anococcygeus muscle. Br J Pharmacol (1978) 2.03
Roles of P2-purinoceptors in the cardiovascular system. Circulation (1991) 2.03
Description of the Genetic Analysis Workshop 11 Collaborative Study on the Genetics of Alcoholism. Genet Epidemiol (1999) 2.01
A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEBS Lett (1995) 1.99
8-phenyltheophylline: a potent P1-purinoceptor antagonist. Eur J Pharmacol (1981) 1.95
Purinergic signalling: pathophysiological roles. Jpn J Pharmacol (1998) 1.94
The expression of P2X3 purinoreceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor. Mol Cell Neurosci (1998) 1.92
P2X receptors in peripheral neurons. Prog Neurobiol (2001) 1.91
Potentiation of the effects of exogenously applied ATP and purinergic nerve stimulation on the guinea-pig taenia coli by dipyridamole and hexobendine. Eur J Pharmacol (1972) 1.85
ATP is released from guinea pig ureter epithelium on distension. Am J Physiol Renal Physiol (2002) 1.84
Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate. J Med Chem (1993) 1.84
Cellular studies of sympathetic denervation produced by 6-hydroxydopamine in the vas deferens. J Pharmacol Exp Ther (1970) 1.79
Purinergic receptors. J Theor Biol (1976) 1.79
Evidence that release of adenosine triphosphate from endothelial cells during increased shear stress is vesicular. J Cardiovasc Pharmacol (2001) 1.77
Effects of adenosine 5'-triphosphate (ATP) and beta-gamma-methylene ATP on the rat urinary bladder. Br J Pharmacol (1979) 1.76
Increased flow-induced ATP release from isolated vascular endothelial cells but not smooth muscle cells. Br J Pharmacol (1991) 1.75
Localization of atrial natriuretic peptide mRNA and immunoreactivity in the rat heart and human atrial appendage. Proc Natl Acad Sci U S A (1987) 1.74
The contributions of noradrenaline and ATP to the responses of the rabbit central ear artery to sympathetic nerve stimulation depend on the parameters of stimulation. Eur J Pharmacol (1986) 1.72
An analysis of the interactions between sympathetic nerve fibers and smooth muscle cells in tissue culture. Dev Biol (1973) 1.72
P2-purinoceptors mediate both vasodilation (via the endothelium) and vasoconstriction of the isolated rat femoral artery. Eur J Pharmacol (1985) 1.71
PPADS selectively antagonizes P2X-purinoceptor-mediated responses in the rabbit urinary bladder. Br J Pharmacol (1993) 1.69
Characteristics of ecto-ATPase of Xenopus oocytes and the inhibitory actions of suramin on ATP breakdown. Pflugers Arch (1995) 1.69
Studies on the stereoselectivity of the P2-purinoceptor. Br J Pharmacol (1983) 1.69
Junction potentials at adrenergic synapses. Pharmacol Rev (1966) 1.67
Evolution of the autonomic innervation of visceral and cardiovascular systems in vertebrates. Pharmacol Rev (1969) 1.66
A pharmacological study of the rabbit saphenous artery in vitro: a vessel with a large purinergic contractile response to sympathetic nerve stimulation. Br J Pharmacol (1987) 1.65
Atropine-resistant excitatory junction potentials in rabbit bladder are blocked by alpha,beta-methylene ATP. Eur J Pharmacol (1985) 1.63
Different P2-purinergic receptor subtypes of endothelium and smooth muscle in canine blood vessels. J Pharmacol Exp Ther (1987) 1.63
Comparison of the inhibitory effects on the guinea-pig taenia coli of adenine nucleotides and adenosine in the presence and absence of dipyridamole. Eur J Pharmacol (1975) 1.63
GABA may be a neurotransmitter in the vertebrate peripheral nervous system. Nature (1979) 1.61
Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci (1996) 1.58
Rapid release of endothelin and ATP from isolated aortic endothelial cells exposed to increased flow. Biochem Biophys Res Commun (1990) 1.58
Full sensitivity of P2X2 purinoceptor to ATP revealed by changing extracellular pH. Br J Pharmacol (1996) 1.57
An ultrastructural and histochemical study of the short-term effects of 6-hydroxydopamine on adrenergic nerves in the domestic fowl. Br J Pharmacol (1970) 1.57
Effects of extracellular pH on agonism and antagonism at a recombinant P2X2 receptor. Br J Pharmacol (1997) 1.57
Molecular cloning and characterization of rat P2Y4 nucleotide receptor. Br J Pharmacol (1998) 1.56
Release of ATP from perfused heart during coronary vasodilatation. Blood Vessels (1974) 1.54
[3H]adenosine triphosphate: release during stimulation of enteric nerves. Science (1971) 1.54
Antagonism of the effects of purinergic nerve stimulation and exogenously applied ATP on the guinea-pig taenia coli by 2-substituted imidazolines and related compounds. Eur J Pharmacol (1973) 1.54
Increased release of ATP from endothelial cells during acute inflammation. Inflamm Res (1998) 1.53
Neural nomenclature. Nature (1971) 1.52
Actions mediated by P2-purinoceptor subtypes in the isolated perfused mesenteric bed of the rat. Br J Pharmacol (1988) 1.52
Dual adrenergic and cholinergic innervation of the cerebral arteries of the rat. An ultrastructural study. Circ Res (1970) 1.52
Increased connexin43 gap junction protein in hamster cardiomyocytes during cold acclimatization and hibernation. Cardiovasc Res (2000) 1.50
Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Am J Physiol Renal Physiol (2004) 1.50
Distribution of P2X receptors in the urinary bladder and the ureter of the rat. J Urol (2000) 1.49
ATP produces vasodilation via P1 purinoceptors and vasoconstriction via P2 purinoceptors in the isolated rabbit central ear artery. Blood Vessels (1985) 1.46
Evidence for a locus on chromosome 1 that influences vulnerability to alcoholism and affective disorder. Am J Psychiatry (2001) 1.46
Effects of purines and pyrimidines on the rat mesenteric arterial bed. Circ Res (1991) 1.45
Peptide-containing neurons in different regions of the submucous plexus of human sigmoid colon. Gastroenterology (1992) 1.44
Evidence for two types of P2-purinoceptor in longitudinal muscle of the rabbit portal vein. Eur J Pharmacol (1985) 1.43
Quantitative trait loci analysis of human event-related brain potentials: P3 voltage. Electroencephalogr Clin Neurophysiol (1998) 1.43
Evidence in support of the P1/P2 purinoceptor hypothesis in the guinea-pig taenia coli. Br J Pharmacol (1981) 1.42
Modulation of the evoked release of noradrenaline in canine saphenous vein via presynaptic receptors for adenosine but not ATP. Eur J Pharmacol (1979) 1.41
The changing face of autonomic neurotransmission. Acta Physiol Scand (1986) 1.41
Colocalization of nitric oxide synthase and NADPH-diaphorase in the myenteric plexus of the rat gut. Neurosci Lett (1992) 1.40
Cytoplasmic filaments in developing and adult vertebrate smooth muscle. J Cell Biol (1971) 1.39
Direct evidence for ATP release from non-adrenergic, non-cholinergic ("purinergic") nerves in the guinea-pig taenia coli and bladder. Eur J Pharmacol (1978) 1.38
Localization of ATP-gated P2X2 and P2X3 receptor immunoreactive nerves in rat taste buds. Neuroreport (1999) 1.37
Isolated human bladder: evidence for an adenine dinucleotide acting on P2X-purinoceptors and for purinergic transmission. Eur J Pharmacol (1989) 1.37
Endothelial cells cultured from human umbilical vein release ATP, substance P and acetylcholine in response to increased flow. Proc Biol Sci (1990) 1.35
A comparative study of electrical field stimulation of the guinea-pig, ferret and marmoset urinary bladder. Eur J Pharmacol (1985) 1.34
Evidence against vasoactive intestinal polypeptide being the non-adrenergic, non-cholinergic inhibitory transmitter released from nerves supplying the smooth muscle of the guinea-pig taenia coli. Eur J Pharmacol (1980) 1.33
A comparison of the excitatory and inhibitory effects of non-adrenergic, non-cholinergic nerve stimulation and exogenously applied ATP on a variety of smooth muscle preparations from different vertebrate species. Br J Pharmacol (1972) 1.33
Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5'-nucleotidase along with endogenous ATP from vascular endothelial cells. Br J Pharmacol (2000) 1.32
Differences in proliferation of primary cultures of vascular smooth muscle cells taken from male and female rats. Blood Vessels (1980) 1.32
Sympathetic ganglia in culture. I. Neurons. Z Zellforsch Mikrosk Anat (1972) 1.31
Ultrastructural localization of choline acetyltransferase in vascular endothelial cells in rat brain. Nature (1985) 1.30